CARDIOVASCULAR JOURNAL OF AFRICA • Vol 23, No 1, February 2012
e10
AFRICA
CARDIOVASCULAR JOURNAL OF AFRICA • Vol 22, No 4, July/August
1
146
14. Remaley AT, Wilding P. Macroenzymes: biochemical characteriza-
tion, clinical significance, and laboratory detection.
Clin Chem
1989;
35
(12): 2261–2270.
15. Inoue K. Macro creatine kinase type 1: a clinically significant marker?
Clin Chem Lab Med
2000;
38
(4): 379.
16. Fahie-Wilson MN, Burrows S, Lawson GJ, Gordon T, Wong W,
Dasgupta B. Prevalence of increased serum creatine kinase activity due
to macro-creatine kinase and experience of screening programmes in
district general hospitals.
Ann Clin Biochem
2007;
44
(Pt 4): 377–383.
17. Stolcpart RS, Olson KL, Delate T, Rasmussen J, Rehring TF, Merenich
JA. The risk for significant creatine kinase elevation with statins.
Am J
Cardiovasc Drugs
2010;
10
(3): 187–192.
